Literature DB >> 10051006

Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995.

H Tulinius1, H Sigvaldason, G Olafsdóttir, L Tryggvadóttir, K Bjarnadóttir.   

Abstract

Information in the Icelandic Cancer Registry on breast cancer and its collection of breast cancer families has been used to elucidate changes in breast cancer incidence by time period and by age, and the effect of degree of relationship and age on the familial risk of breast cancer. Since 1921 the incidence rates have increased, but the increase is significantly greater (2.06% per year) for ages over 44 years than for ages 20-44 (1.20% per year). It has been shown before that when familial risk is computed, the age of the proband influences the risk for the relatives. However, this study shows that the age of the relative is also important and with increasing age the familial risk decreases.

Entities:  

Mesh:

Year:  1999        PMID: 10051006      PMCID: PMC1734292     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  The effect of year of birth on the breast cancer age-incidence curve in Iceland.

Authors:  O Bjarnason; N Day; G Snaedal; H Tulinius
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

2.  Tumours in Iceland. 10. Malignant tumours of the female breast. A histological classification, laterality, survival and epidemiological considerations.

Authors:  H Tulinius; O Bjarnason; H Sigvaldason; G Bjarnadottir; G Olafsdottir
Journal:  APMIS       Date:  1988-03       Impact factor: 3.205

3.  Reproductive factors and breast cancer risk in Iceland. A second cohort study.

Authors:  H Tulinius; H Sigvaldason; J Hrafnkelsson; G Olafsdóttir; L Tryggvadóttir; K Sigurösson
Journal:  Int J Cancer       Date:  1990-12-15       Impact factor: 7.396

4.  Epidemiology of breast cancer in families in Iceland.

Authors:  H Tulinius; H Sigvaldason; G Olafsdóttir; L Tryggvadóttir
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

5.  Study of a single BRCA2 mutation with high carrier frequency in a small population.

Authors:  S Thorlacius; S Sigurdsson; H Bjarnadottir; G Olafsdottir; J G Jonasson; L Tryggvadottir; H Tulinius; J E Eyfjörd
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

6.  High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.

Authors:  G Johannesdottir; J Gudmundsson; J T Bergthorsson; A Arason; B A Agnarsson; G Eiriksdottir; O T Johannsson; A Borg; S Ingvarsson; D F Easton; V Egilsson; R B Barkardottir
Journal:  Cancer Res       Date:  1996-08-15       Impact factor: 12.701

7.  Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries.

Authors:  M Ewertz; S W Duffy; H O Adami; G Kvåle; E Lund; O Meirik; A Mellemgaard; I Soini; H Tulinius
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

8.  Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries.

Authors:  A Engeland; T Haldorsen; S Tretli; T Hakulinen; L G Hörte; T Luostarinen; K Magnus; G Schou; H Sigvaldason; H H Storm
Journal:  APMIS Suppl       Date:  1993

9.  Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic Cancer Registries.

Authors:  H Tulinius; H H Storm; E Pukkala; A Andersen; J Ericsson
Journal:  APMIS Suppl       Date:  1992

10.  Neoplastic diseases in families of breast cancer patients.

Authors:  H Tulinius; G H Olafsdottir; H Sigvaldason; L Tryggvadottir; K Bjarnadottir
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

View more
  4 in total

1.  The effect of a single BRCA2 mutation on cancer in Iceland.

Authors:  H Tulinius; G H Olafsdottir; H Sigvaldason; A Arason; R B Barkardottir; V Egilsson; H M Ogmundsdottir; L Tryggvadottir; S Gudlaugsdottir; J E Eyfjord
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

2.  Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.

Authors:  Laufey T Amundadottir; Sverrir Thorvaldsson; Daniel F Gudbjartsson; Patrick Sulem; Kristleifur Kristjansson; Sigurdur Arnason; Jeffrey R Gulcher; Johannes Bjornsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  PLoS Med       Date:  2004-12-28       Impact factor: 11.069

3.  BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Authors:  Laufey Tryggvadottir; Elinborg J Olafsdottir; Sigfridur Gudlaugsdottir; Steinunn Thorlacius; Jon G Jonasson; Hrafn Tulinius; Jorunn E Eyfjord
Journal:  Breast Cancer Res       Date:  2003-06-24       Impact factor: 6.466

4.  CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status.

Authors:  K Gudmundsdottir; S Thorlacius; J G Jonasson; B F Sigfusson; L Tryggvadottir; J E Eyfjord
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.